Masitinib Prostate Cancer Trial Gains FDA and E...
What is the latest on the masitinib prostate cancer trial, and how could it change treatment for metastatic castrate-resistant prostate cancer (mCRPC)? The masitinib prostate cancer trial recently received simultaneous authorizations from both ...